Hawaii HB1112 establishes a hepatitis prevention program to address high mortality rates from hepatitis B and C.
Hawaii HB1112 creates a hepatitis prevention program to combat high mortality rates from hepatitis B and C. The bill allocates funds for fiscal years 2025-2026 and 2026-2027 to establish and implement the program. The program prioritizes hepatitis awareness and education, increasing access to services, and assuring health equity. The Department of Health is tasked with developing a statewide hepatitis prevention plan, including screening and treatment support. The bill also repeals a previous statute regarding blood transfusions and hepatitis.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.